CagriSema# CagriSema is a fixed-ratio combination of two distinct peptide molecules in a single injection device: Cagrilintide : A long-acting amylin analog with a ~7-day half-life achieved through fatty acid acylation
In autoimmune brain disorders, this release contributes to BBB disruption, microglial priming, and downstream neuroinflammatory cascades
This is beneficial because the whey protein has added nutritional properties that a lipid encapsulation system does not have.* It promotes tissue repair, strengthens the intestines, detoxifies the body, and synergistically works together with glutathione to raise levels of this important antioxidant.* In addition to GSH, whey protein encapsulation has a proven track record of success with other nutrients that suffer from low-bioavailability or breakdown during storage
Shin DM, Walsh GL, Smythe WR, Ro JY, Shin HJ, Swisher SG , Lu C, Fossella FV, Khuri FR, Yalamanchilli A, Hong WK, Khokhar A, Perez-Solar R